Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope

Sandra Piquer, Lionel Valera, Vito Lampasona, Bénédicte Jardin-Watelet, Stéphanie Roche, Claude Granier, Francoise Roquet, Michael R. Christie, Tiziana Giordano, Maria Luisa Malosio, Ezio Bonifacio, Daniel Laune

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

IA-2 and IA-2β are highly related proteins that are autoantigens in type 1 diabetes, and provide a model for developing reagents and assays that distinguish similar proteins with unique autoantibody epitopes. Monoclonal antibodies (mAb) to IA-2 and IA-2β were prepared and tested for their ability to bind to the related proteins and their ability to compete for specific autoantibody epitope binding by sera from patients with type 1 diabetes. Monoclonal antibodies that specifically bound IA-2 (76F) or bound both IA-2 and IA-2β (A9) were isolated and characterized. 76F mAb recognized IA-2 of human, rat and mouse origin in native and denatured forms and had an epitope specificity for residues 626-630 (FEYQD) which are found in the juxtamembrane (JM) region of human and mouse IA-2, but not IA-2β. This region overlaps with the autoantibody epitope JM2. Binding to the 76F monoclonal antibody was specifically inhibited by sera with antibodies to the JM2 epitope but not with antibodies to the adjacent JM1 epitope, indicating that unique epitopes can be distinguished by this approach. 76F mAb has the unique property to distinguish between the two closely related autoantigens IA-2 and IA-2β by targeting an IA-2 specific epitope of the juxtamembrane region. The findings define an approach to develop assays for specific antibody epitope measurements which may be relevant for disease prognosis and monitoring intervention therapies.

Original languageEnglish
Pages (from-to)215-222
Number of pages8
JournalJournal of Autoimmunity
Volume26
Issue number3
DOIs
Publication statusPublished - May 2006

Fingerprint

Epitopes
Monoclonal Antibodies
Autoantibodies
Autoantigens
Type 1 Diabetes Mellitus
Antibodies
ICA512 autoantibody
Proteins
Serum

Keywords

  • Autoantibodies
  • IA-2
  • Monoclonal antibody
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope. / Piquer, Sandra; Valera, Lionel; Lampasona, Vito; Jardin-Watelet, Bénédicte; Roche, Stéphanie; Granier, Claude; Roquet, Francoise; Christie, Michael R.; Giordano, Tiziana; Malosio, Maria Luisa; Bonifacio, Ezio; Laune, Daniel.

In: Journal of Autoimmunity, Vol. 26, No. 3, 05.2006, p. 215-222.

Research output: Contribution to journalArticle

Piquer, S, Valera, L, Lampasona, V, Jardin-Watelet, B, Roche, S, Granier, C, Roquet, F, Christie, MR, Giordano, T, Malosio, ML, Bonifacio, E & Laune, D 2006, 'Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope', Journal of Autoimmunity, vol. 26, no. 3, pp. 215-222. https://doi.org/10.1016/j.jaut.2005.12.001
Piquer, Sandra ; Valera, Lionel ; Lampasona, Vito ; Jardin-Watelet, Bénédicte ; Roche, Stéphanie ; Granier, Claude ; Roquet, Francoise ; Christie, Michael R. ; Giordano, Tiziana ; Malosio, Maria Luisa ; Bonifacio, Ezio ; Laune, Daniel. / Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope. In: Journal of Autoimmunity. 2006 ; Vol. 26, No. 3. pp. 215-222.
@article{2434deb7711b4d87980954a59b0e3613,
title = "Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope",
abstract = "IA-2 and IA-2β are highly related proteins that are autoantigens in type 1 diabetes, and provide a model for developing reagents and assays that distinguish similar proteins with unique autoantibody epitopes. Monoclonal antibodies (mAb) to IA-2 and IA-2β were prepared and tested for their ability to bind to the related proteins and their ability to compete for specific autoantibody epitope binding by sera from patients with type 1 diabetes. Monoclonal antibodies that specifically bound IA-2 (76F) or bound both IA-2 and IA-2β (A9) were isolated and characterized. 76F mAb recognized IA-2 of human, rat and mouse origin in native and denatured forms and had an epitope specificity for residues 626-630 (FEYQD) which are found in the juxtamembrane (JM) region of human and mouse IA-2, but not IA-2β. This region overlaps with the autoantibody epitope JM2. Binding to the 76F monoclonal antibody was specifically inhibited by sera with antibodies to the JM2 epitope but not with antibodies to the adjacent JM1 epitope, indicating that unique epitopes can be distinguished by this approach. 76F mAb has the unique property to distinguish between the two closely related autoantigens IA-2 and IA-2β by targeting an IA-2 specific epitope of the juxtamembrane region. The findings define an approach to develop assays for specific antibody epitope measurements which may be relevant for disease prognosis and monitoring intervention therapies.",
keywords = "Autoantibodies, IA-2, Monoclonal antibody, Type 1 diabetes mellitus",
author = "Sandra Piquer and Lionel Valera and Vito Lampasona and B{\'e}n{\'e}dicte Jardin-Watelet and St{\'e}phanie Roche and Claude Granier and Francoise Roquet and Christie, {Michael R.} and Tiziana Giordano and Malosio, {Maria Luisa} and Ezio Bonifacio and Daniel Laune",
year = "2006",
month = "5",
doi = "10.1016/j.jaut.2005.12.001",
language = "English",
volume = "26",
pages = "215--222",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope

AU - Piquer, Sandra

AU - Valera, Lionel

AU - Lampasona, Vito

AU - Jardin-Watelet, Bénédicte

AU - Roche, Stéphanie

AU - Granier, Claude

AU - Roquet, Francoise

AU - Christie, Michael R.

AU - Giordano, Tiziana

AU - Malosio, Maria Luisa

AU - Bonifacio, Ezio

AU - Laune, Daniel

PY - 2006/5

Y1 - 2006/5

N2 - IA-2 and IA-2β are highly related proteins that are autoantigens in type 1 diabetes, and provide a model for developing reagents and assays that distinguish similar proteins with unique autoantibody epitopes. Monoclonal antibodies (mAb) to IA-2 and IA-2β were prepared and tested for their ability to bind to the related proteins and their ability to compete for specific autoantibody epitope binding by sera from patients with type 1 diabetes. Monoclonal antibodies that specifically bound IA-2 (76F) or bound both IA-2 and IA-2β (A9) were isolated and characterized. 76F mAb recognized IA-2 of human, rat and mouse origin in native and denatured forms and had an epitope specificity for residues 626-630 (FEYQD) which are found in the juxtamembrane (JM) region of human and mouse IA-2, but not IA-2β. This region overlaps with the autoantibody epitope JM2. Binding to the 76F monoclonal antibody was specifically inhibited by sera with antibodies to the JM2 epitope but not with antibodies to the adjacent JM1 epitope, indicating that unique epitopes can be distinguished by this approach. 76F mAb has the unique property to distinguish between the two closely related autoantigens IA-2 and IA-2β by targeting an IA-2 specific epitope of the juxtamembrane region. The findings define an approach to develop assays for specific antibody epitope measurements which may be relevant for disease prognosis and monitoring intervention therapies.

AB - IA-2 and IA-2β are highly related proteins that are autoantigens in type 1 diabetes, and provide a model for developing reagents and assays that distinguish similar proteins with unique autoantibody epitopes. Monoclonal antibodies (mAb) to IA-2 and IA-2β were prepared and tested for their ability to bind to the related proteins and their ability to compete for specific autoantibody epitope binding by sera from patients with type 1 diabetes. Monoclonal antibodies that specifically bound IA-2 (76F) or bound both IA-2 and IA-2β (A9) were isolated and characterized. 76F mAb recognized IA-2 of human, rat and mouse origin in native and denatured forms and had an epitope specificity for residues 626-630 (FEYQD) which are found in the juxtamembrane (JM) region of human and mouse IA-2, but not IA-2β. This region overlaps with the autoantibody epitope JM2. Binding to the 76F monoclonal antibody was specifically inhibited by sera with antibodies to the JM2 epitope but not with antibodies to the adjacent JM1 epitope, indicating that unique epitopes can be distinguished by this approach. 76F mAb has the unique property to distinguish between the two closely related autoantigens IA-2 and IA-2β by targeting an IA-2 specific epitope of the juxtamembrane region. The findings define an approach to develop assays for specific antibody epitope measurements which may be relevant for disease prognosis and monitoring intervention therapies.

KW - Autoantibodies

KW - IA-2

KW - Monoclonal antibody

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=33646735160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646735160&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2005.12.001

DO - 10.1016/j.jaut.2005.12.001

M3 - Article

C2 - 16503116

AN - SCOPUS:33646735160

VL - 26

SP - 215

EP - 222

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 3

ER -